Platelet inhibitors and hydroxyethyl starch: safe and cost-effective interventions in coronary artery surgeryHICKS, G. L. JR; JENSEN, L. A; NORSEN, L. H et al.The Annals of thoracic surgery. 1985, Vol 39, Num 5, pp 422-425, issn 0003-4975Article

Plaquettes et prostaglandines: perspectives pharmacologiques = Platelets and prostaglandins: pharmacological perspectivesLECOMPTE, T; SAMAMA, M; DRAY, F et al.Gazette médicale de France (1969). 1984, Vol 91, Num 19, pp 84-86, issn 0016-5557Article

Effect of aspirin and dipyridamole on the patency of lower extremity bypass graftsKOHLER, T. R; KAUFMAN, J. L; SALZMAN, E. W et al.Surgery. 1984, Vol 96, Num 3, pp 462-466, issn 0039-6060Article

Safety of carotid endarterectomy while on clopidogrel (Plavix): Clinical articleWAIT, Scott D; ABLA, Adib A; KILLORY, Brendan D et al.Journal of neurosurgery. 2010, Vol 113, Num 4, pp 908-912, issn 0022-3085, 5 p.Article

Prasugrel development : Claims and achievementsSEREBRUANY, Victor; SHALITO, Inna; KOPYLEVA, Olga et al.Thrombosis and haemostasis. 2009, Vol 101, Num 1, pp 14-22, issn 0340-6245, 9 p.Article

Why have studies of tailored anti-platelet therapy failed so far?SILLER-MATULA, Jolanta M; JILMA, Bernd.Thrombosis and haemostasis. 2013, Vol 110, Num 4, pp 628-631, issn 0340-6245, 4 p.Article

Bon usage des agents antiplaquettairesMT. Médecine thérapeutique. 2012, Vol 18, Num 4, pp 270-277, issn 1264-6520, 8 p.Article

ACTIVATED CYCLOPHOSPHAMIDE ANTICANCER DRUGS: MOLECULAR STRUCTURES OF CIS- AND TRANS-4-HYDROPEROXYISOPHOSPHAMIDESCAMERMAN A; SMITH HW; CAMERMAN N et al.1983; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1983; VOL. 26; NO 5; PP. 679-683; BIBL. 9 REF.Article

TRIMETHOPRIM-SULFAMETHOXAZOLECOCKERILL FR III; EDSON RS.1983; MAYO CLINIC PROCEEDINGS; ISSN 0025-6196; USA; DA. 1983; VOL. 58; NO 3; PP. 147-153; BIBL. 49 REF.Article

Les antiagrégants plaquettaires en 2005 = The antiplatelet therapy in 2005WAUTRECHT, J. C; STERNON, J.Revue médicale de Bruxelles. 2004, Vol 25, Num 6, pp 525-530, issn 0035-3639, 6 p.Article

STRUCTURES OF TWO ISOMERIC BICYCLIC DERIVATIVES OF 4-HYDROPEROXYISOPHOSPHAMIDECAMERMAN N; FAWCETT JK; CAMERMAN A et al.1983; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1983; VOL. 26; NO 5; PP. 683-686; BIBL. 9 REF.Article

Antiplatelet therapy in the perioperative periodENGELEN, S; SINNAEVE, P; VAN DAMME, H et al.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, pp 139-143, issn 0001-5164, 5 p.Conference Paper

Pharmacologie des médicaments antiagrégants = Pharmacology of antiplatelet drugsDE GAETANO, G; CERLETTI, C.Entretiens du Carla (Les). 1985, Vol 4, pp 45-55Article

Dyspnoea after antiplatelet agents : the AZD6140 controversySEREBRUANY, V. L; STEBBING, J; ATAR, D et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 3, pp 529-533, issn 1368-5031, 5 p.Article

Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonistYAMADA, K; SHUTO, K; KUBO, K et al.Archives internationales de pharmacodynamie et de thérapie. 1984, Vol 268, Num 1, pp 141-154, issn 0003-9780Article

Using microbial reduction to synthesize carbacyclinZHUO-FENG XIE; FUNAKOSHI, K; SUEMUNE, H et al.Chemical and pharmaceutical bulletin. 1986, Vol 34, Num 7, pp 3058-3060, issn 0009-2363Article

New antiplatelet agentsSAMAMA, M.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, issn 0001-5164, p. 127Conference Paper

Antiplatelet agents: Current drugs and future trendsMESSMORE, Harry L; JESKE, Walter P; WEHRMACHER, William et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 1, issn 0889-8588, vi, 87-117 [22 p.]Article

Antithrombic drugsFLEMING, J. S; BUYNISKI, J. P; BRUNO, J. J et al.New drugs annual: cardiovascular drugs. 1983, Vol 1, pp 277-316Article

Time-dependent inhibition of platelet aggregation by dopamine and 3-methoxytyramine: important roles of their metabolitesKODAIRA, H; ISHIKAWA, M; KOMODA, Y et al.Biochemical pharmacology. 1984, Vol 33, Num 3, pp 435-441, issn 0006-2952Article

Differentiating haemostasis from thrombosis for therapeutic benefit : Platelets: basic mechanisms and translational implicationsMCFADYEN, James D; JACKSON, Shaun P.Thrombosis and haemostasis. 2013, Vol 110, Num 5, pp 859-867, issn 0340-6245, 9 p.Article

Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO StudyKOHLI, Payal; WALLENTIN, Lars; OTO, Ali et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 6, pp 673-680, issn 0009-7322, 8 p.Article

Platelet function testing and risk of bleeding complicationsLUIS FERREIRO, José; SIBBING, Dirk; ANGIOLILLO, Dominick J et al.Thrombosis and haemostasis. 2010, Vol 103, Num 6, pp 1128-1135, issn 0340-6245, 8 p.Article

Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmeroneLEE, H. S.Bioresource technology. 2006, Vol 97, Num 12, pp 1372-1376, issn 0960-8524, 5 p.Article

Antiplatelet Drugs: A Review of Their Pharmacology and Management in the Perioperative PeriodHALL, Richard; MAZER, C. David.Anesthesia and analgesia. 2011, Vol 112, Num 2, pp 292-318, issn 0003-2999, 27 p.Article